Alzheimer's disease (AD) is the most common neurodegenerative disorder worldwide and
causes severe financial and social burdens. Despite much research on the pathogenesis of …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss
and personality changes, eventually leading to dementia. The pathological hallmarks of AD …

Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no
effective treatment is available for AD. Analysis of transgenic mouse models of AD has …

Alzheimer's disease (AD) is an incurable neurodegenerative disease affecting over 45
million people worldwide. Transgenic mouse models have made remarkable contributions …

Alzheimer's disease (AD), an irreversible neurodegenerative disease that progressively
impairs memory and cognitive judgment, severely affects the quality of life and imposes a …

Alzheimer's disease (AD) impairs memory and causes significant cognitive deficits. The
disease course is prolonged, with a poor prognosis, and thus exacts an enormous economic …

Transgenic mice models for Alzheimer's disease (AD) are essential to the understanding of
disease pathophysiology, develop robust behavioral models and predict outcomes from …

Alzheimer's disease (AD) is the most common neurodegenerative disease and cause of
dementia. Significant strides toward understanding and developing therapies for AD have …

Alzheimer's disease (AD) is the most common origin of dementia in the elderly. Although the
cause of AD remains unknown, several factors have been identified that appear to play a …

A form of dementia distinct from healthy cognitive aging, Alzheimer's disease (AD) is a
complex multi-stage disease that currently afflicts over 50 million people worldwide …